Imatinib does not induce cardiotoxicity at clinically relevant concentrations in preclinical studies.
Wolf A, Couttet P, Dong M, Grenet O, Heron M, Junker U, Laengle U, Ledieu D, Marrer E, Nussher A, Persohn E, Pognan F, Rivière GJ, Roth DR, Trendelenburg C, Tsao J, Roman D.
Wolf A, et al. Among authors: riviere gj.
Leuk Res. 2010 Sep;34(9):1180-8. doi: 10.1016/j.leukres.2010.01.004. Epub 2010 Jan 31.
Leuk Res. 2010.
PMID: 20122731